John V. Oyler was the founder of Telephia, Inc., founded in 1997, where the title held was President from 1997 to 2008. Mr. Oyler was the founder of BioDuro LLC, founded in 2005, serving as Chief Executive Officer from 2005 to 2009. Mr. Oyler is the founder of BeOne Medicines Ltd., founded in 2010, holding the titles of Chairman & Chief Executive Officer since 2016. Current jobs include CEO, CFO, Secretary & Director at BeOne Medicines USA, Inc. Former jobs include Co-Chief Executive Officer at Genta, Inc. from 1997 to 1998; Chief Executive Officer at Galenea Corp. from 2002 to 2004; Director at Biotechnology Innovation Organization from 2019 to 2024; Principal at McKinsey & Co., Inc.; Vice President-Operations at Walden Laboratories, Inc.; and Principal at Sidney Kimmel Cancer Center. Education includes an MBA from Stanford University in 1996 and an undergraduate degree from Massachusetts Institute of Technology in 1990.
John V. Oyler
John V. Oyler was the founder of Telephia, Inc., founded in 1997, where the title held was President from 1997 to 2008. Mr. Oyler was the founder of BioDuro LLC, founded in 2005, serving as Chief Executive Officer from 2005 to 2009. Mr. Oyler is the founder of BeOne Medicines Ltd., founded in 2010, holding the titles of Chairman & Chief Executive Officer since 2016. Current jobs include CEO, CFO, Secretary & Director at BeOne Medicines USA, Inc. Former jobs include Co-Chief Executive Officer at Genta, Inc. from 1997 to 1998; Chief Executive Officer at Galenea Corp. from 2002 to 2004; Director at Biotechnology Innovation Organization from 2019 to 2024; Principal at McKinsey & Co., Inc.; Vice President-Operations at Walden Laboratories, Inc.; and Principal at Sidney Kimmel Cancer Center. Education includes an MBA from Stanford University in 1996 and an undergraduate degree from Massachusetts Institute of Technology in 1990.
Xiao Dong Wang
Xiao Dong Wang is the founder of Joyant Pharmaceuticals, Inc. (founded 2004), National Institute of Biological Sciences (founded 2003) serving as Director since 2003, Sironax Ltd. (founded 2017) serving as Chairman since 2017, and BeOne Medicines Ltd. (founded 2010) serving as Non-Executive Director since 2016. Current jobs include Non-Executive Director at Clover Biopharmaceuticals Ltd. since 2021, Foreign Associate at Chinese Academy of Sciences since 2013, Member of the National Academy of Sciences since 2004, and Professor at Tsinghua University since 2020. Former jobs include Professor at Howard Hughes Medical Institute, Inc. and Professor at The University of Texas Southwestern Medical Center from 2001 to 2010. Education includes an undergraduate degree from Beijing Normal University conferred in 1984 and a doctorate from The University of Texas Southwestern Medical Center.
Xiao Dong Wang
Xiao Dong Wang is the founder of Joyant Pharmaceuticals, Inc. (founded 2004), National Institute of Biological Sciences (founded 2003) serving as Director since 2003, Sironax Ltd. (founded 2017) serving as Chairman since 2017, and BeOne Medicines Ltd. (founded 2010) serving as Non-Executive Director since 2016. Current jobs include Non-Executive Director at Clover Biopharmaceuticals Ltd. since 2021, Foreign Associate at Chinese Academy of Sciences since 2013, Member of the National Academy of Sciences since 2004, and Professor at Tsinghua University since 2020. Former jobs include Professor at Howard Hughes Medical Institute, Inc. and Professor at The University of Texas Southwestern Medical Center from 2001 to 2010. Education includes an undergraduate degree from Beijing Normal University conferred in 1984 and a doctorate from The University of Texas Southwestern Medical Center.
Anthony C. Hooper
Anthony C. Hooper currently works at MannKind Corp., as Independent Director from 2020, HealthCare Institute of New Jersey, as Director, The American Institute for Stuttering, as Director, The Impact Young Lives Foundation, as Director, Amplity, Inc., as Director from 2020, BeOne Medicines Ltd., as Independent Non-Executive Director from 2023, and American Heart Association (New York), as Executive Driector. Mr. Hooper also formerly worked at American Foundation for Suicide Prevention, as Chairman, Capital Health System, Inc., as Executive Director, National Pharmaceutical Council, as Director, Amgen, Inc., as Executive VP-Global Commercial Operations from 2011 to 2018, Bristol Myers Squibb Co., as Senior Vice President-Global Commercial Operations in 2011, John Wyeth & Brother Ltd., as Assistant Vice President-Marketing, and Wyeth Laboratories, Inc., as Assistant Vice President-Global Marketing. Mr. Hooper received his graduate degree in 1978 and Masters Business Admin degree in 1988 from the University of South Africa.
Alessandro Riva
Alessandro Riva was the founder of Intima Bioscience, Inc., founded in 2021, where the title held was Chief Executive Officer from 2021 to 2023. Dr. Riva is also the founder of Breast Cancer International Research Group Ltd.,Cancer International Research Group.. Dr. Riva is Chairman & Chief Executive Officer at Transgene SA since 2023. Dr. Riva is Independent Director at Century Therapeutics, Inc. since 2021. Dr. Riva is Independent Non-Executive Director at BeOne Medicines Ltd. since 2022. Dr. Riva is Independent Director at Bicycle Therapeutics Plc since 2025. Former positions include Chief Executive Officer-Innovation Business at Glenmark Pharmaceuticals Ltd., Director at Ichnos Glenmark Innovation, Inc. in 2021, Director at Century Therapeutics, Inc. in 2021, Executive VP-Oncology Therapeutics at Gilead Sciences, Inc. from 2017 to 2019, President at Novartis Oncology, Inc. from 2005 to 2016, VP, Head-Oncology Development & Medical Affairs at Novartis AG from 2005 to 2016, and EVP, Head-Oncology Development & Medical Affairs at Novartis Pharmaceuticals Corp. Education includes undergraduate and doctorate degrees from the University of Milan.
Margaret Han Dugan
Margaret Han Dugan is currently an Independent Non-Executive Director at BeOne Medicines Ltd. since 2022 and will be Chief Medical Officer at Whitehawk Therapeutics, Inc. starting in 2025. Former positions include Chief Medical Officer at Dracen Pharmaceuticals, Inc. from 2018 to 2023, Chief Medical Officer at Schr?dinger, Inc., Senior VP & Head-Global Program Oncology at Novartis Pharmaceuticals Corp., Director-Oncology Clinical Research at Schering-Plough Corp., and Deputy Director-Clinical Research Oncology at Wyeth Holdings LLC. Education includes undergraduate and doctorate degrees from New York University, conferred in 1977 and 1981 respectively.
Olivier Brandicourt
Dr. Olivier Brandicourt is an Independent Director at Vaxcyte, Inc., an Independent Non-Executive Director at BeOne Medicines Ltd., an Independent Director at Alnylam Pharmaceuticals, Inc., a Chairman at AvenCell Therapeutics, Inc. and a Council Member at International Federation of Pharmaceutical Manufacturers. He is on the Board of Directors at Vaxcyte, Inc., BeOne Medicines Ltd., Dewpoint Therapeutics, Inc., Alnylam Pharmaceuticals, Inc. and National Committee on United States-China Relations, Inc. Dr. Brandicourt was previously employed as an Independent Non-Executive Director by BenevolentAI SA, a Chief Executive Officer & Director by Sanofi, a Chairman-Management Board by Bayer HealthCare AG, a Managing Director by Pfizer Ltd., a Managing Director by Pfizer Overseas Pharmaceuticals, a President & General Manager-Emerging Markets by Pfizer Inc., a Vice President by Warner-Lambert Co., a Vice President by Parke-Davis &Co. (United States), an Executive Council Member by Bayer AG, a Vice President & Member by European Federation of Pharmaceutical Industries & Assns, a Principal by Odyssey Acquisition SA, a Chairman by Pharmaceutical Research & Manufacturers of America, a Chairman by Sanofi Biotechnology SAS, a Chief Executive Officer by Sanofi-Aventis (Singapore) Pte Ltd., and a Trustee by The Children's Aid Society, Inc. He received his graduate degree from Universite Paris Est Creteil Val De Marne and a doctorate degree from Universite Paris Est Creteil Val De Marne.
Shalini Sharp
Shalini Sharp is currently Chairman at Mahzi Therapeutics, Inc., Independent Director at Neurocrine Biosciences, Inc. since 2020, Director at Alameda County Community Food Bank, Independent Director at Organon & Co. since 2021, Independent Director at Septerna, Inc. since 2024, and Independent Non-Executive Director at BeOne Medicines Ltd. since 2024. Former roles include Chief Executive Officer at Elan Corp. Plc from 2001 to 2003, Independent Director at Global Alliance for TB Drug Development from 2015 to 2022, Independent Director at Agenus, Inc. from 2012 to 2018, Independent Director at Array BioPharma, Inc. from 2017 to 2019, Independent Director at Precision BioSciences, Inc. from 2018 to 2022, Independent Director at Sutro Biopharma, Inc. from 2018 to 2023, Independent Director at Mirati Therapeutics, Inc. from 2021 to 2024, Director at Panacea Acquisition Corp. from 2020 to 2021, Chief of Staff at Elan Pharmaceuticals LLC from 1998 to 2003, Chief Financial Officer & Senior VP-Finance at Ultragenyx Pharmaceutical, Inc. from 2012 to 2020, and Treasurer & Vice President at Dimension Therapeutics, Inc. Education includes an MBA from Harvard Business School and undergraduate studies at Harvard College.
Felix James Baker
Felix James Baker is the founder of Baker Bros. Advisors LP, founded in 2000, serving as Managing Member. Current jobs include Chairman at Kymera Therapeutics, Inc. starting 2026; Non-Executive Chairman at Bicycle Therapeutics Plc starting 2025; Lead Independent Director at Kiniksa Pharmaceuticals Ltd. since 2015; Director at Kiniksa Pharmaceuticals Corp.; Independent Director at Kodiak Sciences, Inc. since 2015; Lead Independent Director at Kiniksa Pharmaceuticals International Plc since 2024; Director at N-Power Medicine, Inc.; Non-Executive Director at BeOne Medicines Ltd. starting 2026; Manager at Fbb2 LLC; Co-Managing Partner at Baker Bros. Advisors GP LLC; Partner at FBB Associates; and Trustee at Memorial Sloan Kettering Cancer Center. Former jobs include Chairman at Seagen, Inc. from 2022 to 2023; Chairman at Synageva BioPharma Corp. from 2011 to 2015; Chairman at Talis Biomedical Corp. from 2013 to 2023; Director at Neurogen Corp. from 1999 to 2008; Independent Director at Alexion Pharmaceuticals, Inc. from 2015 to 2021; Director at Trimeris, Inc. from 2004 to 2011; Director at AnorMED, Inc.; Director at ConjuChem, Inc. from 1994 to 2006; Independent Director at Genomic Health, Inc. from 2012 to 2019; Director at ConjuChem Biotechnologies, Inc. from 2001 to 2009; Director at SlipChip Corp.; Independent Director at Ardea Biosciences, Inc. from 2010 to 2012; Director at Aquinox Pharmaceuticals, Inc.; Director at Presidio Pharmaceuticals, Inc.; Director at ConjuChem Biotechnologies, Inc.; Independent Director at IGM Biosciences, Inc. from 2021 to 2025; and Owner at VaxGen, Inc. Education includes undergraduate and doctorate degrees from Stanford University.
Elizabeth F. Mooney
Elizabeth F. Mooney began a role as Director at BeOne Medicines Ltd. in 2026 and continues in this position.
Charles L. Sawyers
Charles L. Sawyers is the founder of Aragon Pharmaceuticals, Inc., founded in 2009, and Oric Pharmaceuticals, Inc., founded in 2014. Current jobs include Chairman of the Human Oncology & Pathogenesis Program at Memorial Sloan Kettering Cancer Center since 2006, Director at BeOne Medicines Ltd. starting in 2026, Senior Advisor at Arsenal Capital Management LP, Member of the National Academy of Sciences, Member of the American Academy of Arts & Sciences, Member of the National Academy of Medicine (United States), and Professor at Weill Cornell Graduate School of Medical Sciences since 2008. Former jobs include Independent Non-Executive Director at Novartis AG from 2013 to 2025, Chief Associate at the University of California, Los Angeles from 1996 to 2006, President of the American Association for Cancer Research from 2013 to 2014, President of the American Society for Clinical Investigation, Trustee at Cold Spring Harbor Laboratory, Inc., and Science Partner at The Column Group LLC. Education includes undergraduate studies at Princeton University and a doctorate from The Johns Hopkins University School of Medicine.
提供，免责声明：天汇财经、Factset及其他信息供应商努力确保所提供信息的准确性和可靠性，但对于其正确性或可靠性则不予担保，且对于因不正确或疏漏所造成的任何损失或损坏概不负责(无论是有关民事过失、合同或其他方面)。